FIN 711 Week 3 New Venture Financing Needs by Stage Example

How Much Money, When and From Whom: Mapping TerraSorb's Cash Burn, Milestones and Funding Sources From Seed Through Series B Against the Financial Growth Cycle

[Student Name]

University of Phoenix

FIN/711: Financial Measures of Value Added

Week 3 Assignment

[Instructor Name]

[Date]

TerraSorb and all figures are composites written for a model paper; financing concepts, program features and research findings come from the sources listed and are stated generally.

TerraSorb, the composite Minneapolis soil carbon sensor startup, raised $2.4 million of seed funding eight months ago. It has about $1.3 million left and spends about $160,000 a month, rising as it hires field technicians for pilots. Its board asked the chief executive for a financing plan through the company's expected Series B round. A venture's financing plan is really a plan for proving things, because each round is priced on what the company has proved since the last one. This paper builds that plan.

Burn and Runway

Monthly net burn, spending minus revenue, is about $160,000 now and will rise to about $190,000 as pilot programs begin in spring. At that pace, the remaining $1.3 million lasts about seven to eight months. Raising a round typically takes four to six months from first meetings to cash. The company must begin raising its Series A within two months, ideally after reaching at least one milestone that changes its value, or it will negotiate under time pressure.

Stages Defined by What Must Be Proved

Each stage has a purpose. The seed stage proves the sensor works in the field. The Series A stage proves that a carbon registry will accept TerraSorb's measurement method and that agricultural cooperatives will pay for it in pilots. The Series B stage proves that sales can be repeated at a cost per acre that supports a profitable business and that manufacturing can scale. Each round should fund the company through the next proof with at least six months of buffer.

Sizing the Series A

Registry approval, three paid pilots and a second sensor generation require about 20 months at an average burn of about $380,000 a month, or about $7.6 million, plus a buffer, for a raise of about $8 million. If investors value the company at about $20 million before the money, the post-money valuation is $28 million and new investors own about 28.6 percent.

Grants as Early Capital

Federal research grants through the Small Business Innovation Research program, including awards from the Department of Agriculture, fund feasibility and development work without taking equity. Phase I awards are modest and short, and Phase II awards are larger and run over two years. TerraSorb won a Phase I award last year and has applied for Phase II to fund its second-generation sensor. Grants reduce dilution, but they arrive slowly, restrict how money is spent and fund research rather than sales.

Angels and Seed Funds

TerraSorb's seed round came from a regional seed fund and eight angel investors, several of them agricultural executives. Kerr et al. (2014) found that startups backed by organized angel groups were more likely to survive and grow than similar firms the groups narrowly declined, suggesting that angels add value beyond money. For TerraSorb, angels with farm industry knowledge opened doors to cooperatives.

Venture Capital and Strategic Investors

The Series A will likely come from a venture fund focused on climate and agricultural technology, possibly joined by a strategic investor such as a seed or fertilizer company. Strategic investors bring distribution and credibility but may seek rights that limit future sales to their competitors. The board will weigh those terms against the benefits.

The Financial Growth Cycle

Berger and Udell (1998) proposed that firms move along a financial growth cycle: the youngest and least transparent rely on insiders, family and angels; as they grow and build track records, they gain access to venture capital and then to bank debt and public markets. The cycle reflects information asymmetry: outside investors and lenders need evidence before committing. TerraSorb's path so far fits the cycle, moving from founders and grants to angels and a seed fund.

Where the Evidence Complicates the Cycle

Robb and Robinson (2014) studied a large sample of new U.S. firms and found that outside debt, mainly bank loans and credit lines often secured by founders' personal assets, was a larger source of financing than outside equity even in the first years. Few startups raise venture capital at all. TerraSorb, with high technical risk and no revenue, fits the venture path, but its founders did use a personal home equity line to fund the first prototype, an example of the debt the textbook sequence leaves out.

Debt Later in the Path

After the Series A, venture lenders may offer a term loan equal to roughly a quarter to a third of the equity raised, with warrants, extending runway without immediate dilution. Equipment financing can fund sensor manufacturing lines. Week 6 examines these options.

The Series B

If the Series A milestones are met, TerraSorb expects to raise about $25 million roughly three years from now to fund manufacturing scale and a national sales team, selling perhaps 25 percent of the company.

Dilution

After the seed round, the founders own about 72 percent, seed investors 20 percent and the option pool 8 percent. A Series A selling 28.6 percent and expanding the option pool by 5 percentage points leaves existing holders with about 66 percent of their previous stake, reducing the founders to about 48 percent. A Series B selling 25 percent with a 3-point pool expansion leaves the founders at about 34 percent. Each round's higher price limits the dilution, which is why reaching milestones before raising matters.

Experimentation and Financing

Kerr and Nanda (2015) argued that financing innovation involves funding experiments whose outcomes are uncertain, so investors stage their commitments and can abandon ventures that fail early tests. Staged financing explains why TerraSorb raises money in rounds tied to proofs rather than all at once, and why each round's price depends on the experiments completed.

Bridge Financing if Milestones Slip

Plans assume milestones arrive on time; they often do not. If registry approval slips by six months, TerraSorb would reach the end of its Series A runway without the proof needed for a Series B at a higher price. The board therefore discussed a contingency: existing investors could provide a bridge loan convertible into the next round at a discount, typically 15 to 20 percent, buying time without setting a new valuation. Bridges protect the company from a forced sale or a down round but signal that progress is slower than planned, so the plan builds a six-month buffer into each round to make a bridge less likely.

Gaps Between Theory and Practice

TerraSorb's experience departs from theory in two ways: founders' personal debt played a role the venture finance literature underemphasizes, and federal grants, rarely central in finance research, provided nondilutive capital at the riskiest stage. Both suggest research on how public grants and personal credit interact with venture financing.

Conclusion

TerraSorb's financing plan follows its milestones: a Series A of about $8 million to prove registry approval and paid pilots, debt and grants to stretch runway and a Series B to scale. The path broadly fits the financial growth cycle, with evidence on startup debt and grants adding nuance, and careful timing keeps founder dilution near a third by Series B.

References

Berger, A. N., & Udell, G. F. (1998). The economics of small business finance: The roles of private equity and debt markets in the financial growth cycle. Journal of Banking & Finance, 22(6-8), 613-673. https://doi.org/10.1016/S0378-4266(98)00038-7

Kerr, W. R., Lerner, J., & Schoar, A. (2014). The consequences of entrepreneurial finance: Evidence from angel financings. The Review of Financial Studies, 27(1), 20-55. https://doi.org/10.1093/rfs/hhr098

Kerr, W. R., & Nanda, R. (2015). Financing innovation. Annual Review of Financial Economics, 7, 445-462. https://doi.org/10.1146/annurev-financial-111914-041825

Robb, A. M., & Robinson, D. T. (2014). The capital structure decisions of new firms. The Review of Financial Studies, 27(1), 153-179. https://doi.org/10.1093/rfs/hhs072